I dunno about that NBB. I just spoke to a friend of mine at AMLN (bumped into him at lunch) and he seemed pretty upbeat about his company adding $450M or so to its cash pile. I think they'll be doing some pretty amazing things with that money (as well as the other half-billion in revenues they could rake in this year).
AMLN - comments?
Collapse
X
-
Time to buy puts.Originally posted by NY4EverSAN DIEGO (AP) - Biopharmaceutical company Amylin Pharmaceuticals Inc. said Monday it plans to sell up to 9.8 million shares via a public offering.
The company filed with regulators to sell 8.5 million shares and has granted the underwriters the option to buy an additional 1.3 million shares.
Leave a comment:
-
-
Guest repliedSAN DIEGO (AP) - Biopharmaceutical company Amylin Pharmaceuticals Inc. said Monday it plans to sell up to 9.8 million shares via a public offering.
The company filed with regulators to sell 8.5 million shares and has granted the underwriters the option to buy an additional 1.3 million shares.
Leave a comment:
-
-
Byetta scrips surpass 30,000 this week
The scrips for Symlin and Byetta both are increasing at a stellar rate now. 2006 drug revenues could very well pass $500M, doubling the analyst estimates.
AMLN had prescriptions reported by IMS America
this morning for recently approved diabetes drugs
Symlin and Byetta. Total prescriptions for Byetta
in its fortieth full week ended March 3 were
30,657, of which 17,599 were new prescriptions
up from 26,387 total and 15,738 new Rxs
respectively in the prior week. With 1-month
starter packs being provided to key prescribers,
we believe that these numbers underestimate true
patient starts.
Summary
Total prescriptions for Symlin for the week ended
March 3 were 2,694 with new Rxs of 1,274, up
from 2,405 total and 1,142 new Rxs in the prior
week. Overall, more than 38,000 new
prescriptions have been written for Symlin in its
first nine months of launch.
Leave a comment:
-
-
Guest repliedAMLN - About To Soar?
This article, prominently featured in the March 2nd New York Times, is one of the most prominent, definitive, and encouraging pieces that I've seen on Byetta to date. Also, my Endocrinologist feels that it may be time for me to begin taking it, further boosting sales.
Leave a comment:
-
-
Not ready for the fork.
Spike's target hit. And it ain't done yet.
Leave a comment:
-
-
Guest repliedTextbook broadening top formation.
Leave a comment:
-
-
Guest replied<< What is your opinion? Is AMLN done bottoming out? >>
Not to be glib but we won't know until it starts moving up again on rising (or at least average) volume. Even a pullback to the 50% retracement level, if it holds, is considered bullish.
Leave a comment:
-
-
Dave,Originally posted by DStecklerAMLN stopped right on the 38.2% retracement of the advance since the 8/23 gap.
Saw your post and went back to the chart. I see how you drew the FIB
from the Top of the Gap up. I haven't done it that way before . . . maybe I don't know what I am doing.
What is your opinion? Is AMLN done bottoming out? Are you looking for further downside (like I am)? Would you be a buyer at these levels and at this time?
Leave a comment:
-
-
Originally posted by New-born babyFRGB isn't the bad one: BEL. This one almost went to zero before regaining its equalibrium at $2..
And Spike is pulling $$ out of it now. Could have pulled $$ on the short side.
Leave a comment:
-
-
I think the FIBs should be drawn this way:Originally posted by LyehopperAnother angle is.... What two points do you choose to pull the retracement from? Could actually be worse than my chart shows if other fib points were chosen.
Any way you cut it: it hasn't bottomed. Get out of the way of that falling piano! Buy the FEB $40 puts. Or the FEB $35 puts.
Leave a comment:
-
-
FRGB isn't the bad one: BEL. This one almost went to zero before regaining its equalibrium at $2.Originally posted by LyehopperWonder if $$MM$$ will consider the charts this time or pull another "FRGB"?
Leave a comment:
-
-
I hear ya dude, I like the way you think.... Another angle is.... What two points do you choose to pull the retracement from? Could actually be worse than my chart shows if other fib points were chosen.Originally posted by New-born babyI'd say a couple of things to ya, LYE-BABY:
1. If you are correct with the Golden Rule retracement of 61.8% at $37.60, you are losing $2 to get there (not my style). I always figured I'd keep the $2 and pick it up again later. Besides, my forecasted bottom may not be the real bottom. It might drop further.
2. I don't know where you entered the stock, but if I wanted this one so bad my play would be sell the calls for FEB $40 for the $1.30. [If fact, I owned AMLN and had sold those $40 calls for $5 (bought them last Friday when AMLN was $43. Sold them yesterday; should have sold them today! Or not at all
]. Doubt she'll pullback up by the 17th. Yes, we are just $39 now, but I am looking for a 100% retracement to $32.60.
3. I could be too pessimistic here. You should take into account that I am a conservative type investor.
4. Ask Spike to confirm this, but the last four days make an "A" downturn. We still need a "B" corrective, and a "C" that falls further South than "A" before we are ready to enter the stock again. No, I'd leave this one.
Look at this chart and you can see why I say what I say:
http://img426.imageshack.us/img426/6554/chart11yl.gif
If AMLN retraces with a chart like it has.... then I guess we could expect every single pick on the "top five grounghog dump" to follow suit. Wonder if $$MM$$ will consider the charts this time or pull another "FRGB"?
Leave a comment:
-
-
Hey NB-Baby.... With a herd of good black cattle it's hard to see that.lolOriginally posted by New-born babyLye,
Something I've been meaning to ask you . . . .
http://img404.imageshack.us/img404/2221/chart12sj.gif
Leave a comment:
-


Leave a comment: